No abstract available
MeSH terms
-
Anticarcinogenic Agents / adverse effects
-
Anticarcinogenic Agents / therapeutic use*
-
Aromatase Inhibitors / adverse effects
-
Aromatase Inhibitors / therapeutic use*
-
Breast Neoplasms / prevention & control*
-
Female
-
Humans
-
Primary Prevention / methods*
-
Raloxifene Hydrochloride / adverse effects
-
Raloxifene Hydrochloride / therapeutic use
-
Selective Estrogen Receptor Modulators / adverse effects
-
Selective Estrogen Receptor Modulators / therapeutic use*
-
Tamoxifen / adverse effects
-
Tamoxifen / therapeutic use
-
Uterine Neoplasms / chemically induced
-
Venous Thromboembolism / chemically induced
Substances
-
Anticarcinogenic Agents
-
Aromatase Inhibitors
-
Selective Estrogen Receptor Modulators
-
Tamoxifen
-
Raloxifene Hydrochloride